Do not treat the numbers: lithium toxicity
| Autor: | Anand Mathilakath, Peter Foulser, Ramin Nilforooshan, Yasmin Abbasi |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Male
Olanzapine Pediatrics medicine.medical_specialty Bipolar Disorder Bipolar I disorder Lithium (medication) Lithium 030204 cardiovascular system & hematology Article Diagnosis Differential Benzodiazepines 03 medical and health sciences 0302 clinical medicine Secondary Prevention medicine Humans 030212 general & internal medicine Bipolar disorder Normal range Psychiatric Status Rating Scales Lithium toxicity business.industry General Medicine Middle Aged medicine.disease Coarse tremor Treatment Outcome business Antipsychotic Agents Kidney disease medicine.drug |
| Zdroj: | BMJ Case Reports. :bcr-2017 |
| ISSN: | 1757-790X |
| DOI: | 10.1136/bcr-2017-220079 |
| Popis: | We describe the case of a 62-year-old man with a history of bipolar disorder, previously stable on lithium for over 20 years, who presented with a manic relapse and signs of lithium toxicity in the form of a coarse tremor. Serum lithium levels were in the normal range, and the patient had stage 3 chronic kidney disease. He was admitted for treatment under Section 2 of the Mental Health Act, and after stopping lithium was started on olanzapine. Signs of lithium toxicity improved after withdrawal of lithium. This case highlights the need to treat normal serum lithium levels with caution in patients showing signs of clinical lithium toxicity. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|